Viewing Study NCT00632268


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-02 @ 1:42 PM
Study NCT ID: NCT00632268
Status: COMPLETED
Last Update Posted: 2013-08-21
First Post: 2008-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer
Sponsor: National Taiwan University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module